http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103347884-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4811e7eae15e0f1e32cc6a222ce30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03d0f52bb4069f8a19d70dcfb697c67a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C239-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-18
filingDate 2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce68d13af1f1be8ff132c1d36717987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571354ae35e02719311c227f21480bd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f782cd325f43127a4537731b8569121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97ded3a3acfc93b78fe9bc3558a4ad1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35db2daf1f843b8cd75a262059abc0fb
publicationDate 2013-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103347884-A
titleOfInvention Pyrazino[2,3-d]isoxazole derivatives
abstract The object of the present invention is to provide compounds useful as intermediates in the production of pyrazinecarboxamide derivatives such as 6-fluoro-3-hydroxy-2-pyrazinecarboxamide. The present invention provides pyrazino[2,3-d]iso Azole derivatives (where X represents a halogen atom, hydroxyl or sulfamoyloxy, and Y represents -C(=O)R or -CN (wherein R represents a hydrogen atom, alkoxy, aryloxy, alkyl, aryl radical or amino)). Formula (I)
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114478404-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113735784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104817511-A
priorityDate 2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009041473-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468262697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466188016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466671595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466671594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466598169

Total number of triples: 36.